Transcriptional regulation of human osteopontin promoter by C/EBPα and AML-1 in metastatic cancer cells

Yan Nien Liu, Bean Bu Kang, J. H. Chen

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Osteopontin (OPN) is a secreted glycoprotein produced by osteoclasts, macrophages, T cells, hematopoietic cells, and vascular smooth muscle cells. It contributes to macrophage homing and cellular immunity. It also mediates neovascularization, inhibits apoptosis, and plays important roles in extracellular matrix remodeling and angiogenesis. These properties are also characteristics of metastatic cancer cells. Consequently, the OPN gene was found to be upregulated among various metastatic cancer cells. This suggests that OPN is involved in tumor metastasis. How the OPN gene is upregulated in metastatic cancer cells remains to be illustrated. Thus, we investigated the transcriptional activation of the OPN promoter in the human metastatic cancer cell line A2058. We cloned the OPN promoter, and serial deletion analysis of the OPN promoter showed that the region between -170 and -127 may act as an enhancer to control the OPN gene in metastatic tumor cells. This region was found to contain overlapped AML-1 and C/EBP binding site motifs. Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPα (CCAAT/ enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127. Surprisingly, the gel-shift experiments did not show supershift complex formation between AML-1 and C/EBPα. Functional analysis showed that the C/EBPα was more potent than the complex of AML-1 and its cofactor CBFβ to upregulate the OPN promoter. In addition, AML-1 and C/EBPα did not exhibit transactivation additively or synergistically. Our results suggest that AML-1 and C/ EBPα play an important role in the upregulation of the OPN gene in metastatic tumor cells.

Original languageEnglish
Pages (from-to)278-288
Number of pages11
JournalOncogene
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 8 2004
Externally publishedYes

Fingerprint

CCAAT-Enhancer-Binding Protein-alpha
Osteopontin
Neoplasms
Protein Binding
Transcriptional Activation
Genes
Up-Regulation
Gels
Macrophages
Binding Sites
Electrophoretic Mobility Shift Assay
Osteoclasts
Vascular Smooth Muscle
Recombinant Proteins
Genetic Promoter Regions
Cellular Immunity
Smooth Muscle Myocytes
Extracellular Matrix
Glycoproteins

Keywords

  • AML-1
  • C/EBPα
  • Gene expression
  • Metastasis
  • OPN

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Transcriptional regulation of human osteopontin promoter by C/EBPα and AML-1 in metastatic cancer cells. / Liu, Yan Nien; Kang, Bean Bu; Chen, J. H.

In: Oncogene, Vol. 23, No. 1, 08.01.2004, p. 278-288.

Research output: Contribution to journalArticle

@article{b142febb979d479082bad446e43ffcdf,
title = "Transcriptional regulation of human osteopontin promoter by C/EBPα and AML-1 in metastatic cancer cells",
abstract = "Osteopontin (OPN) is a secreted glycoprotein produced by osteoclasts, macrophages, T cells, hematopoietic cells, and vascular smooth muscle cells. It contributes to macrophage homing and cellular immunity. It also mediates neovascularization, inhibits apoptosis, and plays important roles in extracellular matrix remodeling and angiogenesis. These properties are also characteristics of metastatic cancer cells. Consequently, the OPN gene was found to be upregulated among various metastatic cancer cells. This suggests that OPN is involved in tumor metastasis. How the OPN gene is upregulated in metastatic cancer cells remains to be illustrated. Thus, we investigated the transcriptional activation of the OPN promoter in the human metastatic cancer cell line A2058. We cloned the OPN promoter, and serial deletion analysis of the OPN promoter showed that the region between -170 and -127 may act as an enhancer to control the OPN gene in metastatic tumor cells. This region was found to contain overlapped AML-1 and C/EBP binding site motifs. Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPα (CCAAT/ enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127. Surprisingly, the gel-shift experiments did not show supershift complex formation between AML-1 and C/EBPα. Functional analysis showed that the C/EBPα was more potent than the complex of AML-1 and its cofactor CBFβ to upregulate the OPN promoter. In addition, AML-1 and C/EBPα did not exhibit transactivation additively or synergistically. Our results suggest that AML-1 and C/ EBPα play an important role in the upregulation of the OPN gene in metastatic tumor cells.",
keywords = "AML-1, C/EBPα, Gene expression, Metastasis, OPN",
author = "Liu, {Yan Nien} and Kang, {Bean Bu} and Chen, {J. H.}",
year = "2004",
month = "1",
day = "8",
doi = "10.1038/sj.onc.1207022",
language = "English",
volume = "23",
pages = "278--288",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Transcriptional regulation of human osteopontin promoter by C/EBPα and AML-1 in metastatic cancer cells

AU - Liu, Yan Nien

AU - Kang, Bean Bu

AU - Chen, J. H.

PY - 2004/1/8

Y1 - 2004/1/8

N2 - Osteopontin (OPN) is a secreted glycoprotein produced by osteoclasts, macrophages, T cells, hematopoietic cells, and vascular smooth muscle cells. It contributes to macrophage homing and cellular immunity. It also mediates neovascularization, inhibits apoptosis, and plays important roles in extracellular matrix remodeling and angiogenesis. These properties are also characteristics of metastatic cancer cells. Consequently, the OPN gene was found to be upregulated among various metastatic cancer cells. This suggests that OPN is involved in tumor metastasis. How the OPN gene is upregulated in metastatic cancer cells remains to be illustrated. Thus, we investigated the transcriptional activation of the OPN promoter in the human metastatic cancer cell line A2058. We cloned the OPN promoter, and serial deletion analysis of the OPN promoter showed that the region between -170 and -127 may act as an enhancer to control the OPN gene in metastatic tumor cells. This region was found to contain overlapped AML-1 and C/EBP binding site motifs. Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPα (CCAAT/ enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127. Surprisingly, the gel-shift experiments did not show supershift complex formation between AML-1 and C/EBPα. Functional analysis showed that the C/EBPα was more potent than the complex of AML-1 and its cofactor CBFβ to upregulate the OPN promoter. In addition, AML-1 and C/EBPα did not exhibit transactivation additively or synergistically. Our results suggest that AML-1 and C/ EBPα play an important role in the upregulation of the OPN gene in metastatic tumor cells.

AB - Osteopontin (OPN) is a secreted glycoprotein produced by osteoclasts, macrophages, T cells, hematopoietic cells, and vascular smooth muscle cells. It contributes to macrophage homing and cellular immunity. It also mediates neovascularization, inhibits apoptosis, and plays important roles in extracellular matrix remodeling and angiogenesis. These properties are also characteristics of metastatic cancer cells. Consequently, the OPN gene was found to be upregulated among various metastatic cancer cells. This suggests that OPN is involved in tumor metastasis. How the OPN gene is upregulated in metastatic cancer cells remains to be illustrated. Thus, we investigated the transcriptional activation of the OPN promoter in the human metastatic cancer cell line A2058. We cloned the OPN promoter, and serial deletion analysis of the OPN promoter showed that the region between -170 and -127 may act as an enhancer to control the OPN gene in metastatic tumor cells. This region was found to contain overlapped AML-1 and C/EBP binding site motifs. Gel-mobility-shift assays using the A2058 nuclear extract and AML-1a or C/EBPα (CCAAT/ enhancer binding protein alpha) recombinant protein indicated that these two transcription factors can bind to the overlapped AML-1 /C/EBP binding site motifs on the OPN regulatory sequence from -147 to -127. Surprisingly, the gel-shift experiments did not show supershift complex formation between AML-1 and C/EBPα. Functional analysis showed that the C/EBPα was more potent than the complex of AML-1 and its cofactor CBFβ to upregulate the OPN promoter. In addition, AML-1 and C/EBPα did not exhibit transactivation additively or synergistically. Our results suggest that AML-1 and C/ EBPα play an important role in the upregulation of the OPN gene in metastatic tumor cells.

KW - AML-1

KW - C/EBPα

KW - Gene expression

KW - Metastasis

KW - OPN

UR - http://www.scopus.com/inward/record.url?scp=0942279489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942279489&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1207022

DO - 10.1038/sj.onc.1207022

M3 - Article

VL - 23

SP - 278

EP - 288

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 1

ER -